CLEVELAND, June 18, 2013 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced it will be demonstrating its highly anticipated uPRO™ offering at the 49th Annual Drug Information Association Meeting in Boston on June 24th – June 26th.
The DATATRAK ONE™ software suite is being expanded to collect Patient Reported Outcomes in order to provide the market with the most complete unified eClinical® solution for data collection. Patient-driven data is collected in the same system as clinical data and is accessible in real-time. When deploying a DATATRAK ONE uEDC and uPRO™ solution, study team members have a single location to view and manage all study-related data.
"As direct interactions with patients become more prevalent in clinical trials, our clients are asking for innovative ways to further their drug development initiatives," stated Craig Wigginton, DATATRAK's Chief Technology Officer. "The introduction of our uPRO™ product for the collection of patient reported outcomes provides clients with a single solution for managing all patient data in real-time – eliminating the time and cost of setting up and managing a second, separate system."
The DATATRAK ONE™ suite of products empowers Sponsors and CROs to efficiently design, deliver and manage clinical trials. The unified, end-to-end clinical research offering extends the DATATRAK ONE CLINICAL ERP™ system by providing a comprehensive suite of seven products – all sold standalone or together and delivered globally in a secure cloud:
uCTMS™, uDesign™, uEDC™, uIRT™, uPRO™, uSafety™ and uTrain™
Join DATATRAK Thought Leaders:
Tweet: DATATRAK to introduce uPRO™ solution at DIA http://ow.ly/m7tJT
DATATRAK International is a worldwide technology and services company delivering unified eClinical® solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE™ software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I – Phase IV drug and device studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit http://www.datatrak.com.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on May 15, 2013 announcing its results for the first quarter of 2013. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.